Topic Collection Cover Page

COVID-19 Vaccine Resources
Topic Collection
September 19, 2022

Topic Collection: COVID-19 Vaccine Resources

This Topic Collection focuses on vaccine-specific plans, tools, templates, and other immediately implementable resources to help with COVID-19 preparedness, response, recovery, and mitigation efforts.

The distribution and administration of vaccines to prevent COVID-19 should build on established plans. Federal, state, territorial, local, and tribal governments and their healthcare and other emergency preparedness partners have conducted extensive planning on the most effective methods to distribute and administer medical countermeasures – including vaccines – in their communities. Refer to the ASPR TRACIE Mass Distribution and Dispensing of Medical Countermeasures Topic Collection for related resources.  Resources marked with an asterisk (*) appear in more than one category.

Please refer to the NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines and CDC’s Coronavirus Disease 2019 webpage for the most up-to-date guidance on COVID-19 outbreak management.

If you have COVID-19 best or promising practices, plans, tools, or templates to share with your peers, please visit the ASPR TRACIE Information Exchange COVID-19 Information Sharing Page (registration required) and place your resources under the relevant topic area. Resources specific to Vaccines can be placed under the COVID-19 Vaccines Resources Topic.

Sections Navigation

Toggle Open/Close

General Resources

American Nurses Association. (2020). Guiding Principles for Nurses and the COVID-19 Vaccines. (Added 12/23/2020.)
This document identifies access, transparency, equity, efficacy, and safety as the guiding principles for the vaccination of nurses and other healthcare professionals.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
ASPR TRACIE. (2018). Mass Distribution and Dispensing of Medical Countermeasures.
This Topic Collection provides links to federal, state, local, and tribal programs and resources, lessons learned, plans, tools, and templates, courses, and guidance that can help planners address the need to effectively distribute and administer medical countermeasures (MCMs) to a large number of persons in a short period of time, particularly through mass dispensing efforts led by public health authorities.
Rate:
Favorite:
1
You must Login to add a comment
  • This item doesn't have any comments
ASPR TRACIE. (2020). Influenza Epidemic/ Pandemic. U.S. Department of Health and Human Services, Office of the Assistant Secretary of Preparedness and Response.
The resources in this Topic Collection include the lessons learned from the 2009 pandemic, strategies for maintaining “business as usual” for healthcare facilities, checklists, and others that can help emergency medical staff plan for and respond to a pandemic.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
ASPR TRACIE. (2021). COVID-19 Vaccine Planning and Considerations.
This ASPR TRACIE TA response includes links to resources related to the approval, allocation, distribution, and administration of vaccines to prevent COVID-19.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Association of University Centers on Disabilities. (2020). Frequently Asked Questions (FAQ): COVID-19 Vaccine Distribution Considerations for the Disability Community. (Added 12/30/2020.)
This document answers frequently asked questions about COVID-19 vaccine approval, manufacturing, allocation, and distribution for state and local disability leaders.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2021). COVID-19 ACIP Vaccine Recommendations. (Added 8/24/2021.) U.S. Department of Health and Human Services.
This page lists all recommendations by the Advisory Committee on Immunization Practices related to the COVID-19 vaccine.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2021). COVID-19 Vaccine Effectiveness and Safety. (Added 8/24/2021.) U.S. Department of Health and Human Services.
This page lists all reports published in the Morbidity and Mortality Weekly Report related to the safety and effectiveness of COVID-19 vaccines.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* COVID-19 Real-Time Learning Network. (2020). Vaccines and Immunity. (Added 12/23/2020.) Centers for Disease Control and Prevention and Infectious Diseases Society of America.
This page provides a broad range of information on vaccine development and distribution planning.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Federal Emergency Management Agency. (2020). COVID-19 Pandemic: Vaccination Planning FAQ. (Added 12/23/2020.) U.S. Department of Homeland Security.
This document answers frequently asked questions related to COVID-19 vaccination planning.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Gavi. (2020). There are Four Types of COVID-19 Vaccines: Here’s How They Work. (Added 12/23/2020.)
This page provides an overview of the four different COVID-19 vaccine types in development: whole virus, protein subunit, nucleic, and viral vector.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Pharmaceutical Supply and Payment Chain Coalition. (2020). Guiding Principles for Safe and Efficacious COVID-19 Vaccine Development, Distribution, Allocation, and Mass Immunization. (Added 12/23/2020.)
This statement by 17 organizations offers seven guiding principles related to COVID-19 vaccine. It calls for transparent and scientifically rigorous vaccine development, approval, and post-marketing surveillance processes; equitable allocation of vaccine; consistent and clear public engagement and communication; a well-coordinated national distribution strategy; accounting for the readiness of the local vaccination infrastructure and workforce; prioritization and promotion of COVID-19 vaccination; and ensuring affordability and access.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Food and Drug Administration. (2020). COVID-19 Vaccines. (Added 12/23/2020.) U.S. Department of Health and Human Services.
This landing page provides links to the latest information on the development and approval of COVID-19 vaccines.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* U.S. Food and Drug Administration. (2020). Vaccine Development – 101. (Added 12/23/2020.) U.S. Department of Health and Human Services.
This webpage describes the steps that vaccine developers follow when seeking FDA approval of a vaccine.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Education and Training

American Medical Association. (2020). COVID-19 and Vaccine Development. (Added 12/28/2020.)
This page includes links to webinars and other educational information related to COVID-19 vaccination.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2020). COVID-19 Vaccine Training Module. (Added 12/28/2020.) U.S. Department of Health and Human Services.
This online training module provides information to healthcare workers on COVID-19 vaccine approval and safety, storage, handling, administration, and reporting.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Centers for Disease Control and Prevention. (2021). COVID-19 Vaccination Training Programs and Reference Materials for Healthcare Professionals. (Added 2/10/2021.) U.S. Department of Health and Human Services.
This document provides a list of training and educational materials related to immunization practices. It also includes COVID-19 vaccine-specific information.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* COVID-19 Real-Time Learning Network. (2020). Vaccines and Immunity. (Added 12/23/2020.) Centers for Disease Control and Prevention and Infectious Diseases Society of America.
This page provides a broad range of information on vaccine development and distribution planning.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Immunization Action Coalition. (2020). Skills Checklist for Vaccine Administration. (Added 2/10/2021.)
This checklist is a self-assessment tool developed for healthcare staff who administer immunizations. Supervisors can also use this tool to identify roles and responsibilities for staff who administer vaccines.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Minnesota Department of Health. (2020). COVID-19 Vaccine Trainings for Health Professionals. (Added 12/28/2020.)
This page includes links to webinars and on-demand training for health professionals involved in the COVID-19 vaccination effort.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Oregon Health Authority. (2020). COVID-19 Training for Vaccine Providers. (Added 12/30/2020.)
This page includes links to training required or recommended in the state of Oregon, manufacturer-specific training, and other sources of optional training.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
TRAIN. (2020). COVID-19 Vaccination Training Programs for Healthcare Professionals. (Added 12/28/2020.) (Free registration required.)
This page offers links to vaccination training programs for health professionals.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Plans, Tools, and Templates

AABB. (2022). Toolkit for COVID-19 Convalescent Plasma (CCP) under Emergency Use Authorization (EUA). (Added 1/11/2021.)
This frequently updated toolkit includes tabulated information about changes to the Emergency Use Authorization (EUA) for COVID-19 Convalescent Plasma (CCP); detailed information about blood donor referrals after COVID-19 vaccination or CCP infusion; flowcharts on investigational and EUA use, collection, and testing and labeling of CCP, and a sample flowchart for updating a deferral policy for vaccines to help evaluate donor risk following vaccination.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
American Society of Health-System Pharmacists. (2020). ASHP COVID-19 Vaccine Planning Tool for Pharmacists and Pharmacies. (Added 12/23/2020.)
This tool guides the involvement of pharmacists and pharmacy staff in institutional and community COVID-19 vaccine planning efforts. It addresses integration with institutional planning, vaccine supply and distribution, infrastructure, personnel, patient care, vaccine safety monitoring and surveillance, and legislative and regulatory controls.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* American Society of Health-System Pharmacists. (2021). COVID-19 Vaccine Security, Storage, and Handling Resource Guide. (Added 1/11/2021.)
This resource guide includes information on general security and storage, procurement, pharmacy security and storage, transport, and patient care area security and storage of COVID-19 vaccine as well as management of COVID-19 vaccine returns to pharmacy and community pharmacy considerations.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Ariadne Labs. (2020). Vaccine Allocation Planner for COVID-19. (Added 12/23/2020.) Brigham and Women’s Hospital, Harvard T.H. Chan School of Public Health, and The Surgo Foundation.
This tool allows planners to enter the state population of prioritized groups, available COVID-19 vaccine doses, and allocation approach (proportional to population or according to two different vulnerability indexes) to view the distribution of vaccine across counties and population groups.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
ASPR TRACIE. (2021). Mass Vaccination Plans.
This ASPR TRACIE TA response includes mass vaccination plans to support COVID-19 vaccine administration efforts.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Association of Immunization Managers. (2021). Vaccine Confidence Toolkit.
This resource page includes links to various materials to help communicate about COVID-19 vaccination.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Centers for Disease Control and Prevention. (2020). Checklist of Best Practices for Vaccination Clinics Held at Satellite, Temporary, or Off-Site Locations. (Added 2/10/2021.) U.S. Department of Health and Human Services.
This checklist provides step-by-step guidance for clinic coordinators/supervisors who oversee vaccination clinics held at satellite, temporary, or offsite locations. It includes guidelines and best practices, as set forth by the Centers for Disease Control and Prevention (CDC), as it pertains to vaccine shipment, transport, storage, handling, preparation, administration, and documentation.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Centers for Disease Control and Prevention. (2020). COVID-19 Vaccination Communication Toolkit. (Added 12/23/2020.) U.S. Department of Health and Human Services.
This page includes materials that providers can use to communicate with patients about vaccination to prevent COVID-19. Materials include fact sheets, posters, stickers, slides, social media messages, videos, and communications guides.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2020). COVID-19 Vaccination Program Interim Playbook for Jurisdiction Operations. (Added 12/23/2020.) U.S. Department of Health and Human Services.
This playbook can help public health departments and their response partners plan and operationalize their COVID-19 vaccination programs.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2020). COVID-19 Vaccination Program Operational Guidance. (Added 12/23/2020.) U.S. Department of Health and Human Services.
This page provides information on COVID-19 vaccination eligibility and operational considerations. It also includes links to the executive summaries of the COVID-19 vaccination plans of state, territorial, and local public health agencies and their partners.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Centers for Disease Control and Prevention. (2020). Long-Term Care Facility Toolkit: Preparing for COVID-19 Vaccination at Your Facility. (Added 12/30/2020.) U.S. Department of Health and Human Services.
This toolkit includes various resources to support COVID-19 vaccination of long-term care facility residents and staff.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Centers for Disease Control and Prevention. (2020). Vaccine Storage and Handling Toolkit. (Added 12/23/2020.) U.S. Department of Health and Human Services.
This toolkit shares best practices for vaccine storage and handling. It includes an addendum focused on COVID-19 vaccines.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2021). COVID-19 Vaccination Program Interim Playbook for Jurisdictions Operations Annex - Considerations for Increasing COVID-19 Vaccination: Reaching and Increasing Uptake in Priority Populations. (Added 2/4/2021.) U.S. Department of Health and Human Services.
This annex to the COVID-19 Vaccination Program Interim Playbook for Jurisdiction Operations provides guidance on when and how to transition from vaccinating initial to additional priority populations; a framework for balancing equitable access, service delivery, and demand; tools for engaging priority populations and increasing vaccine confidence; and strategies to leverage private-public partnerships.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Federal Emergency Management Agency. (2021). Community Vaccination Centers Playbook. (Added 2/9/2021.) U.S. Department of Homeland Security.
This document provides guidance for federal agencies that are tasked with supporting existing and newly established Community Vaccination Centers. It addresses interagency coordination, resource support, facility setup, and other requirements that may necessitate federal support.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Federal Emergency Management Agency. Office of Equal Rights. (2021). FEMA Advisory: Civil Rights Considerations During COVID-19 Vaccine Distribution Efforts. (Added 3/25/2021.) U.S. Department of Homeland Security.
This checklist offers federal, state, local, and tribal authorities elements to ponder in the categories of inclusive planning, effective communication access, language access, and physical accessibility, as they plan equitable vaccine distribution in their communities.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Indian Health Service. (2020). COVID-19 Pandemic Vaccine Plan. (Added 12/23/2020.) U.S. Department of Health and Human Services.
This plan details how the Indian Health Service will prepare for and distribute COVID-19 vaccine to its Direct Service facilities, Tribal health programs, and Urban Indian Organizations.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* National Association of Community Health Centers. (2021). Microplanning for COVID-19 Vaccine Delivery in Health Centers. (Added 2/4/2021.)
This resource page includes a 2-page infographic summarizing planning steps for health centers preparing to administer vaccines and a PowerPoint presenting the steps along with links to additional resources and answers to frequently asked questions.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Department of Defense. (2020). DoD Announces COVID-19 Vaccine Distribution Plan. (Added 12/23/2020.)
This press release announces the Department of Defense’s plan to distribute and administer COVID-19 vaccine to uniformed service members, dependents, retirees, civilian employees, and select contract personnel. It includes links to the department’s COVID-19 vaccine guidance and vaccine distribution and population schema.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Department of Housing and Urban Development and U.S. Department of Health and Human Services. (2021). COVID-19 Vaccinations and Testing Toolkit. (Added 6/15/2021.)
This toolkit assists community health centers and U.S. Housing and Urban Development (HUD)-assisted housing and homeless programs interested in partnering to provide public and low-income housing residents and people experiencing homelessness with COVID-19 testing, vaccination, and health care.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Department of Veterans Affairs. (2020). COVID-19 Vaccination Plan for the Veterans Health Administration. (Added 12/23/2020.)
This plan describes department activities related to vaccination of veterans and staff, including prioritization of healthcare workers and veterans residing in long-term care facilities.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
UCHealth. (2021). COVID-19 Mass Vaccination Drive-Through Playbook. (Added 2/22/2021.)
This playbook outlines planning and operations related to a two-day COVID-19 mass vaccination event that vaccinated nearly 10,000 individuals. It includes information on how diverse partners collaborated to plan and execute the joint event, offers lessons learned from the experience, and provides appendices with site maps, sample signage, clinic workflows for each staff role, the safety and mitigation plan, a clinical supplies list, staff checklists, a patient welcome packet, radio scripts, and staffing sign-up form.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Post-Vaccination Issues

American Society of Hematology. (2021). Vaccine-induced Immune Thrombotic Thrombocytopenia: Frequently Asked Questions. (Added 4/16/2021.)
These frequently asked questions - expected to be updated as additional information becomes available - provide details about the diagnosis and treatment of vaccine-induced thrombotic thrombocytopenia (VITT) occurring following COVID-19 vaccination.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
CDC COVID-19 Response Team and U.S. Food and Drug Administration. (2021). Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021. (Added 1/25/2021.) Morbidity and Mortality Weekly Report. 70..
This report documents initial reports of adverse events following administration of the first dose of the Moderna COVID-19 vaccine. Between December 21, 2020 and January 10, 2021, 10 cases of anaphylaxis were reported following administration of 4,041,396 first doses of the vaccine.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
CDC COVID-19 Response Team and U.S. Food and Drug Administration. (2021). Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine — United States, December 14–23, 2020. (Added 1/11/2021.) Morbidity and Mortality Weekly Report. 70..
This report details initial reports of adverse events following administration of the first dose of the Pfizer-BioNTech vaccine. Between December 14 and 23, 2020, 21 cases of anaphylaxis were reported following administration of 1,893,360 doses of vaccine.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2020). Post Vaccine Considerations for Residents. (Added 12/28/2020.) U.S. Department of Health and Human Services.
This page offers considerations for residents of long-term care facilities with systemic signs and systems after receiving a COVID-19 vaccine.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2020). V-safe After Vaccination Health Checker. (Added 12/28/2020.) U.S. Department of Health and Human Services.
This page includes information about the smartphone-based tool for personalized check-ins following vaccination to prevent COVID-19. The page offers a description of the tool and registration information.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2021). Clinical Considerations: Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults. U.S. Department of Health and Human Services.
This resource page provides recommendations for clinicians related to reports of myocarditis and pericarditis in adolescents and young adults following mRNA COVID-19 vaccination.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2021). COVID-19 Vaccine Breakthrough Case Investigation and Reporting. (Added 8/24/2021.) U.S. Department of Health and Human Services.
This resource page provides information on investigation and reporting of COVID-19 cases among the vaccinated.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2021). Interim Public Health Recommendations for Fully Vaccinated People. (Added 3/9/2021.) U.S. Department of Health and Human Services.
This guidance provides recommendations on the activities in non-healthcare settings of those fully vaccinated against COVID-19.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Law, Y., Lal, A., Chen, S., et al. (2021). Diagnosis and Management of Myocarditis in Children: A Scientific Statement from the American Heart Association. (Added 8/24/2021.) Circulation. 144(6):e123-e135.
This articles provides information on the immunopathogenesis, causes, diagnosis, treatment, and follow-up of myocarditis in pediatric patients.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Risk Communication Tools and Considerations

#Get Vaccinated. (2020). Provider Resources. (Added 12/28/2020.) American Health Care Association and National Center for Assisted Living .
This toolkit contains various resources to support the #GetVaccinated campaign, including talking points, templates, and media materials.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
American Pharmacists Association. (2021). Vaccine Hesitancy: Understanding and Addressing Vaccine Hesitancy During COVID-19. (Added 1/11/2021.)
This updated fact sheet provides information for pharmacists’ conversations with their customers about immunization, including tips for addressing vaccine hesitancy generally and in racial or ethnic minority populations more specifically.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
American Psychological Association. (2020). Building Vaccine Confidence Through Community Engagement. (Added 12/28/2020.)
This resource highlights attitudes and behaviors associated with vaccines. It offers strategies on building vaccination acceptance and confidence that will be important to the COVID-19 vaccination effort.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
ASPR TRACIE. (2021). Be a COVID-19 Vaccine Champion Webinar.
The speakers discuss the campaign designed to build confidence in and address hesitancy related to COVID-19 vaccines.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Association of Immunization Managers. (2021). Vaccine Confidence Toolkit.
This resource page includes links to various materials to help communicate about COVID-19 vaccination.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Centers for Disease Control and Prevention. (2020). COVID-19 Vaccination Communication Toolkit. (Added 12/23/2020.) U.S. Department of Health and Human Services.
This page includes materials that providers can use to communicate with patients about vaccination to prevent COVID-19. Materials include fact sheets, posters, stickers, slides, social media messages, videos, and communications guides.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2020). U.S. COVID-19 Vaccine Product Information. (Added 12/28/2020.) U.S. Department of Health and Human Services.
This page offers suggestions for healthcare providers on answering patient questions about vaccination to prevent COVID-19.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2020). Vaccine Recipient Education. (Added 12/28/2020.) U.S. Department of Health and Human Services.
This page offers communication strategies to aid healthcare providers in talking with their patients about vaccination to prevent COVID-19.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2020). Vaccines. (Added 12/28/2020.) U.S. Department of Health and Human Services.
This landing page provides information for the public about COVID-19 vaccines, recommendations, administration plans, and safety. It also includes answers to frequently asked questions.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2021). How to Increase COVID-19 Vaccination upon Discharge from Hospitals, Emergency Departments, and Urgent Care Facilities. U.S. Department of Health and Human Services.
This web page provides a best practices checklist, billing guidance, vaccine eligibility information, and other resources to aid healthcare providers in encouraging vaccination in discharged patients.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Chou, W., Burgdorf, C., Gaysynsky, A., and Hunter, C.. (2021). COVID-19 Vaccination Communication: Applying Behavioral and Social Science to Address Vaccine Hesitancy and Foster Vaccine Confidence. (Added 3/25/2021.) National Institutes of Health.
The authors describe foundational communication elements and specific objectives for federal agency vaccine communications, along with those of their state and local partners, broken down by audience groups. It includes an extensive list of hyperlinked references.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Gonzales, A., Lee, E., Grigorescu, V., et al. (2021). Overview of Barriers and Facilitators in COVID-19 Vaccine Outreach. (Added 10/8/2021) U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation.
This report shares lessons learned, describes COVID-19 vaccine outreach evidence, and offers examples of successful vaccination outreach strategies.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Lin, C., Tu, P., and Beitsch, L. (2021). Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review. (Added 1/11/2021.) Vaccines. 9(1):16..
This article includes one flow diagram of the study’s search and selection process and three charts illustrating data about vaccine hesitancy as reported in 126 studies and surveys, selected from searches of academic literature, news, and official reports that were published by October 20, 2020.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
McKenna, Maryn. (2020). Vaccines are Here. We Have to Talk About Side Effects. (Added 12/28/2020.) Wired.
This article describes the side effects that many people should expect to experience following COVID-19 vaccination and discusses the importance of communicating this possibility with the public now to counter disinformation about the vaccine and misattribution of symptoms that overlap with COVID-19 infection.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Association of Community Health Centers. (2022). COVID-19 Communications Toolkit for Health Centers.
This toolkit includes various resources to assist health center staff in communicating with patients about vaccination. It includes key messages, answers to frequently asked questions, social media graphics, selfie signs, and links to additional resources.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Resource Center for Refugees, Immigrants, and Migrants (NRC-RIM). (2022). Vaccine Central. University of Minnesota.
This webpage includes various resources for vaccine providers working with refugee, immigrant, and migrant communities to increase COVID-19 vaccination rates.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
New York City Health + Hospitals. (2021). Be a COVID19 Vaccine Champion Toolkit. (Added 5/13/2021.)
This toolkit includes: a manual providing a summary of what clinicians need to know about COVID-19 vaccines and how to communicate with patients about them; a guide to learning about COVID-19 vaccines; a PowerPoint template for hosting a webinar or lecture; audience poll questions; and instructions on how to use the documents.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Public Health Institute. (2020). Communicating about the COVID-19 Vaccines: Guidance and Sample Messages for Public Health Practitioners. (Added 12/28/2020.)
This page provides tips and sample language for communicating with the public about COVID-19 vaccination.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Schoch-Spana, M., Brunson, E., Long, R., et al.. (2020). The Public’s Role in COVID-19 Vaccination: Planning Recommendations Informed by Design Thinking and the Social, Behavioral, and Communication Sciences. (Added 12/28/2020.) Johns Hopkins Bloomberg School of Public Health, Center for Health Security.
The authors – members of the Working Group on Readying Populations for COVID-19 Vaccines – offer five recommendations to advance public understanding of, access to, and acceptance of COVID-19 vaccines.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Trust for America’s Health. (2020). Ensuring COVID-19 Vaccine Access, Safety, and Utilization: Building Vaccination Confidence in Communities of Color. (Added 12/28/2020.)
This webinar offers suggestions on how to build vaccine confidence and access in communities of color.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
We Can Do This. (2022). Updated Vaccines. U.S. Department of Health and Human Services.
This page includes links to videos, social media messages, posters and flyers, and other informational content to help clinicians educate patients on the importance of COVID-19 vaccine boosters.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
World Health Organization. (2021). Tackling COVID-19 Misinformation: A Social Media Toolkit for Healthcare Practitioners.
This toolkit provides messages and techniques that healthcare practitioners may use to increase vaccine confidence among their patients. Users may download desktop or mobile versions of the toolkit.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Vaccine Allocation and Equity

* Ariadne Labs. (2020). Vaccine Allocation Planner for COVID-19. (Added 12/23/2020.) Brigham and Women’s Hospital, Harvard T.H. Chan School of Public Health, and The Surgo Foundation.
This tool allows planners to enter the state population of prioritized groups, available COVID-19 vaccine doses, and allocation approach (proportional to population or according to two different vulnerability indexes) to view the distribution of vaccine across counties and population groups.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
CEPI. (2020). COVAX: CEPI’s Response to COVID-19. (Added 12/28/2020.)
This page describes the partnership of CEPI, Gavi, and the World Health Organization geared towards making two billion doses of COVID-19 vaccine fairly and equitably accessible to participating countries.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Dooling, K., Marin, M., Wallace, M., et al.. (2020). The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine – United States, December 2020. (Added 12/30/2020.)
This report outlines the Advisory Committee on Immunization Practices’ COVID-19 vaccine allocation recommendations for Phase 1b (persons age 75 and older and non-healthcare frontline essential workers) and Phase 1c (persons age 65-74, essential workers not included in Phase 1b, and persons 16-64 with high-risk medical conditions).
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Dooling, K., McClung, N., Chamberland, M., et al.. (2020). The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine – United States, 2020. (Added 12/28/2020.) Morbidity and Mortality Weekly Report 69(49);1857-1859.
This report provides the rationale of the Advisory Committee on Immunization Practices behind recommending that initial, limited supply of COVID-19 vaccine be allocated to healthcare workers and residents of long-term care facilities during Phase 1a.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Emanuel, E., Persad, G., Kern, A., et al.. (2020). An Ethical Framework for Global Vaccine Allocation. (Added 12/28/2020.) Science. 369(6509):1309-1312.
The authors of this article describe a three-phased Fair Priority Model for distribution of COVID-19 vaccine that prioritizes preventing urgent harms earlier. Phase 1 addresses premature deaths and other irreversible health effects, phase 2 addresses other enduring health harms and economic and social deprivations, and phase 3 addresses community transmission.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Federal Emergency Management Agency. Office of Equal Rights. (2021). FEMA Advisory: Civil Rights Considerations During COVID-19 Vaccine Distribution Efforts. (Added 3/25/2021.) U.S. Department of Homeland Security.
This checklist offers federal, state, local, and tribal authorities elements to ponder in the categories of inclusive planning, effective communication access, language access, and physical accessibility, as they plan equitable vaccine distribution in their communities.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
McClung, N., Chamberland, M., Kinlaw, K., et al. (2020). The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine – United States, 2020. (Added 12/28/2020.) Morbidity and Mortality Weekly Report. 69(47):1782-1786.
The report identifies four ethical principles that guide the Advisory Committee on Immunization Practices’ recommendations for initial allocation of limited COVID-19 vaccine: maximizing benefits and minimizing harms, promoting justice, mitigating health inequities, and promoting transparency.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Mullard, A.. (2020). How COVID Vaccines Are Being Divvied Up Around the World. (Added 12/28/2020.) Nature.
This article summarizes the quantities of various COVID-19 vaccine candidates that have been pre-ordered and their planned distribution in various countries.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
The National Academies of Sciences, Engineering, and Medicine. (2020). Framework for Equitable Allocation of COVID-19 Vaccine. (Added 12/28/2020.) The National Academies Press.
This consensus study report offers a phased framework based on ethical and procedural principles for equitable allocation of COVID-19 vaccine that reduces severe morbidity and mortality and negative societal effects of the pandemic. In addition to the framework, the authors addressed implementation challenges related to program administration, risk communication and community engagement, vaccine acceptance, and global equity in allocation.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Toner, E., Barnill, A., Krubiner, C., et al.. (2020). Interim Framework for COVID-19 Vaccine Allocation and Distribution in the United States. (Added 12/28/2020.) Johns Hopkins Bloomberg School of Public Health, Center for Health Security.
This report offers an ethical allocation framework and suggestions for vaccine distribution. The framework is based on wellbeing and promoting the common good; justice, fairness, and equity; legitimacy, trust, and sense of ownership in a pluralist society; combining and balancing ethical values and principles; adapting to changing conditions and evolving evidence; and linking ethical values and principles with policy goals and objectives.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
World Health Organization. (2020). WHO SAGE Roadmap for Prioritizing Uses of COVID-19 Vaccines in the Context of Limited Supply. (Added 12/28/2020.)
This roadmap provides guidance on COVID-19 vaccine prioritization decisions within countries based on various epidemiological setting and vaccine supply scenarios.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
World Health Organization. (2020). WHO SAGE Values Framework for the Allocation and Prioritization of COVID-19 Vaccination. (Added 12/28/2020.)
This framework offers six core principles and twelve objectives to guide the prioritization of groups for COVID-19 vaccination when supply is limited.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Vaccine Development and Approval

Bloomberg. (2020). Bloomberg COVID-19 Vaccine Tracker. (Added 12/30/2020.)
This page tracks the development status of the most promising COVID-19 vaccine candidates and global purchasing commitments for each.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
London School of Hygiene and Tropical Medicine. (2020). COVID-19 Vaccine Tracker. (Added 12/30/2020.)
This frequently updated page provides a summary of vaccine candidates and trial timelines, key attributes of registered trials, a map of planning and ongoing efficacy trials, published safety, immunogenicity, and efficacy data, summary of vaccine distribution information, and frequently asked questions.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Governors Association. (2020). Update on COVID-19 Vaccine Development. (Added 12/30/2020.)
This memo summarizes U.S. government efforts to spur development of a vaccine to prevent COVID-19.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Oliver, S., Gargano, J., Marin, M., et al.. (2020). The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine – United States, December 2020. (Added 12/30/2020.) Morbidity and Mortality Weekly Report 69(50);1922-1924.
This report documents the rationale supporting ACIP’s interim recommendation to use the Pfizer BioNTech vaccine in persons age 16 and older.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Oliver, S., Gargano, J., Marin, M., et al.. (2020). The Advisory Committee on Immunization Practices’ Interim Recommendations for Use of Moderna COVID-19 Vaccine – United States, December 2020. (Added 12/30/2020.) Morbidity and Mortality Weekly Report. 69(5152):1653-1656.
This report documents the rationale supporting ACIP’s interim recommendation to use the Moderna vaccine in persons age 18 and older.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Oliver, S., Gargano, J., Scobie, H., et al. (2021). The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021. (Added 3/2/2021.) Morbidity and Mortality Weekly Report. 70(9):329-332.
This report documents the rationale supporting ACIP's interim recommendation to use the Johnson & Johnson/Janssen vaccine in persons age 18 and older.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Food and Drug Administration. (2020). Development and Licensure of Vaccines to Prevent COVID-19. (Added 12/30/2020.) U.S. Department of Health and Human Services.
This guidance document assists sponsors in the clinical development and licensure of vaccines to prevent COVID-19.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Food and Drug Administration. (2020). Emergency Use Authorization for Vaccines to Prevent COVID-19. (Added 12/30/2020.) U.S. Department of Health and Human Services.
This guidance document assists sponsors in understanding the data and information required to support the issuance of an emergency use authorization for a vaccine to prevent COVID-19.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Food and Drug Administration. (2020). The Path for a COVID-19 Vaccine from Research to Emergency Use Authorization. (Added 12/30/2020.) U.S. Department of Health and Human Services.
This graphic illustrates the key steps in the COVID-19 vaccine approval process.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* U.S. Food and Drug Administration. (2020). Vaccine Development – 101. (Added 12/23/2020.) U.S. Department of Health and Human Services.
This webpage describes the steps that vaccine developers follow when seeking FDA approval of a vaccine.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Vaccine Logistics - Administration

Agency for Healthcare Research and Quality. (2021). Invest in Trust: A Guide for Building COVID-19 Vaccine Trust and Increasing Vaccination Rates Among CNAs. (Added 10/7/2021) U.S. Department of Health and Human Services.
This guide is intended to help nursing home administrators build trust in vaccines among their certified nursing assistants and overcome barriers to vaccination.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
American Medical Association. (2020). AMA Announces Vaccine-Specific CPT Codes for Coronavirus Immunizations. (Added 12/30/2020.)
This page is a reference for the Current Procedural Terminology code set for COVID-19 vaccine-specific codes.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
American Pharmacists Association. (2021). Authority to Immunize During COVID-19: Pharmacists, Pharmacy Technicians, and Pharmacy Interns. (Added 1/11/2021.)
To help pharmacists, pharmacy technicians, and pharmacy interns know about the expectations and requirements for their authority to immunize during the COVID-19 pandemic, this updated table lists requirements for COVID-19 vaccinations and childhood vaccinations.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* American Society of Health-System Pharmacists. (2021). COVID-19 Vaccine Security, Storage, and Handling Resource Guide. (Added 1/11/2021.)
This resource guide includes information on general security and storage, procurement, pharmacy security and storage, transport, and patient care area security and storage of COVID-19 vaccine as well as management of COVID-19 vaccine returns to pharmacy and community pharmacy considerations.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
ASHP, ISMP, USP. (2021). FAQ for Optimizing COVID-19 Vaccine Preparation and Safety. (Added 3/25/2021.) American Society of Health-System Pharmacists.
This illustrated document answers questions about the safe preparation of vaccines and related medical supplies and about optimizing doses per vial safely and effectively. It includes a list of hyperlinked references and is intended to serve as a living document with newer questions to be added later.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
ASPR TRACIE. (2020). Hospital Operations Toolkit for COVID-19: Administration – Vaccine Logistics.
This section of the Hospital Operations Toolkit for COVID-19 discusses strategies for hospitals to administer allocated vaccine to their staff.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
ASPR TRACIE. (2021). Vaccination Clinic Resources.
This ASPR TRACIE TA response provides resources, such as checklists, tailored towards bringing external volunteers onboard at a public-facing vaccination clinic.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
ASPR TRACIE. (2023). COVID-19 Vaccination Quick Links.
ASPR TRACIE created this list to assist clinicians in quickly finding the most relevant and current information about COVID-19 vaccines available in the United States, their intended populations, recommendations for their use, effectiveness and safety issues, potential adverse events to be aware of, the effects of SAR-COV-2 variants on the vaccinated, and resources to help communicate with patients. Additional resources are also listed to access more detailed information.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Association of State and Territorial Health Officials. (2020). COVID-19 Vaccine Comparison. (Added 12/30/2020.)
This table compares the target populations, efficacy, administration, possible side effects, and safety for pregnant/lactating individuals for the Pfizer/BioNTech, Moderna, and Johnson & Johnson/Janssen COVID-19 vaccines.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Centers for Disease Control and Prevention. (2020). Checklist of Best Practices for Vaccination Clinics Held at Satellite, Temporary, or Off-Site Locations. (Added 2/10/2021.) U.S. Department of Health and Human Services.
This checklist provides step-by-step guidance for clinic coordinators/supervisors who oversee vaccination clinics held at satellite, temporary, or offsite locations. It includes guidelines and best practices, as set forth by the Centers for Disease Control and Prevention (CDC), as it pertains to vaccine shipment, transport, storage, handling, preparation, administration, and documentation.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2020). Considerations for Planning Curbside/Drive-Through Vaccination Clinics. U.S. Department of Health and Human Services.
This resource page provides information for those planning curbside or drive-through vaccination clinics. It offers steps for planning the clinic and what to do before, during, and after the vaccination encounter. It also includes links to additional resources.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2020). Guidance for Planning Vaccination Clinics Held at Satellite, Temporary, or Off-Site Locations. (Added 12/30/2020.) U.S. Department of Health and Human Services.
This page provides guidance to inform vaccination clinic planning. It applies to both routine vaccination clinics as well as those established for emergencies, such as COVID-19. In addition to outlining activities necessary to operate a vaccination clinic, checklists are available for supplies and best practices.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Centers for Disease Control and Prevention. (2020). Long-Term Care Facility Toolkit: Preparing for COVID-19 Vaccination at Your Facility. (Added 12/30/2020.) U.S. Department of Health and Human Services.
This toolkit includes various resources to support COVID-19 vaccination of long-term care facility residents and staff.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2020). Resource Guide on How to Respond to Problems with Purchasing Needles for Influenza and Other Routine Vaccinations. (Added 12/15/2020.)
This page addresses possible concerns about the recommended use and supply of needles during this period of high demand due to COVID-19, influenza, and other vaccinations.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Centers for Disease Control and Prevention. (2020). Vaccine Storage and Handling Toolkit. (Added 12/23/2020.) U.S. Department of Health and Human Services.
This toolkit shares best practices for vaccine storage and handling. It includes an addendum focused on COVID-19 vaccines.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Centers for Disease Control and Prevention. (2021). COVID-19 Vaccination Training Programs and Reference Materials for Healthcare Professionals. (Added 2/10/2021.) U.S. Department of Health and Human Services.
This document provides a list of training and educational materials related to immunization practices. It also includes COVID-19 vaccine-specific information.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2021). Strategies for Sharps Disposal Container Use During Supply Shortages.
The information on this page can help COVID-19 vaccinators and others assisting at COVID-19 mass vaccination sites reduce needlestick injuries and exposures.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2023). Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates. (Added 12/30/2020.) U.S. Department of Health and Human Services.
This page offers clinical considerations for the Pfizer-BioNTech, Moderna, and Johnson & Johnson/Janssen COVID-19 vaccines related to: administration; interchangeability with other COVID-19 vaccine products; coadministration with other vaccines; booster doses, vaccination of those with SARS-CoV-2 infection or exposure; vaccination of persons with underlying medical conditions, immunocompromised persons, pregnant or lactating people, and adolescents; patient counseling; contraindications and precautions; reporting of vaccine adverse events; and interpretation of SARS-CoV-2 test results in vaccinated persons. It includes a table to inform the triage of persons presenting for vaccination.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Medicare & Medicaid Services. (2020). COVID-19 Vaccine Policies and Guidance. (Added 12/30/2020.) U.S. Department of Health and Human Services.
This page links to toolkits on COVID-19 vaccine enrollment, coverage, reimbursement, and other information for healthcare providers, state Medicaid programs and Children’s Health Insurance Programs, health insurers, and those helping consumers and beneficiaries.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Cybersecurity and Infrastructure Security Agency. (2020). Primer on Safe and Efficient Handling of Dry Ice. (Added 12/30/2020.) U.S. Department of Homeland Security.
This document provides handling information for owners and operators related to dry ice.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Federal Emergency Management Agency. (2021). Community Vaccination Centers Playbook. (Added 2/9/2021.) U.S. Department of Homeland Security.
This document provides guidance for federal agencies that are tasked with supporting existing and newly established Community Vaccination Centers. It addresses interagency coordination, resource support, facility setup, and other requirements that may necessitate federal support.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Health Industry Distributors Association. (2020). COVID-19 Vaccine Orders Will Include Needles and Syringes. (Added 12/30/2020.)
This alert summarizes the needles, syringes, alcohol prep pads, and personal protective equipment that will be included in ancillary kits accompanying COVID-19 vaccine shipments.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Health Resources and Services Administration. (2021). COVID-19 Vaccine Booster Planning Checklist. (Added 10/7/2021) U.S. Department of Health and Human Services.
This planning checklist is intended to help health centers assess their readiness to administer COVID-19 vaccine boosters.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Immunization Action Coalition. (2020). Skills Checklist for Vaccine Administration. (Added 2/10/2021.)
This checklist is a self-assessment tool developed for healthcare staff who administer immunizations. Supervisors can also use this tool to identify roles and responsibilities for staff who administer vaccines.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* National Association of Community Health Centers. (2021). Microplanning for COVID-19 Vaccine Delivery in Health Centers. (Added 2/4/2021.)
This resource page includes a 2-page infographic summarizing planning steps for health centers preparing to administer vaccines and a PowerPoint presenting the steps along with links to additional resources and answers to frequently asked questions.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Association of State EMS Officials. (2021). Emergency Medical Services Personnel as Vaccinators: Status by State. (Added 2/19/2021.)
This report displays the current state-level regulatory conditions related to administration of vaccine via the intramuscular route by paramedics, advanced emergency medical technicians, other intermediate level emergency medical services providers, emergency medical technicians, and emergency medical responders.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* National Governors Association. (2020). Information Systems and Data Flow for COVID-19 Vaccine Distribution and Administration. (Added 12/30/2020.)
This paper discusses the processes and systems involved in the allocation, ordering, distribution, inventory management, tracking, administration, documentation, and reporting involved in the COVID-19 mass vaccination campaign.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Occupational Safety and Health Administration. (2021). Keeping Workers Safe at COVID-19 Vaccination Sites. (Added 2/4/2021.) U.S. Department of Labor.
This one-pager provides tips on workforce safety at COVID-19 vaccination sites. A Spanish version is also available at https://www.osha.gov/Publications/OSHA4110.pdf.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
The American College of Obstetricians and Gynecologists. (2020). Vaccinating Pregnant and Lactating Patients Against COVID-19. (Added 12/30/2020.)
This practice advisory reviews the available evidence related to COVID-19 vaccination in pregnant and lactating patients and offers recommendations to guide conversations between providers and their patients about whether to be vaccinated.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* U.S. Department of Health and Human Services. (2020). Guidance for PREP Act Coverage for Qualified Pharmacy Technicians and State-Authorized Pharmacy Interns for Childhood Vaccines, COVID-19 Vaccines, and COVID-19 Testing. (Added 12/30/2020.)
This guidance allows state-licensed pharmacists to order and state-licensed pharmacists and registered pharmacy interns to administer COVID-19 vaccines under the Public Readiness and Emergency Preparedness Act when certain requirements are met.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Food and Drug Administration. (2021). FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines. U.S. Department of Health and Human Services.
This January 4, 2021 statement by the Commissioner and Director of the Center for Biologics Evaluation and Research at the U.S. Food and Drug Administration reiterates the importance of receiving the second dose of the Pfizer/BioNTech and Moderna COVID-19 vaccines according to the authorized intervals between doses.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Vaccine Logistics - Distribution

Centers for Disease Control and Prevention. (2020). Understanding the Pharmacy Partnership for Long-Term Care Program. (Added 12/30/2020.) U.S. Department of Health and Human Services.
This page describes the Pharmacy Partnership for Long-Term Care Program that enables participating pharmacies to provide COVID-19 vaccination onsite at long-term care facilities.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Cybersecurity and Infrastructure Security Agency. (2020). Cold Storage Cyber Custodial Care. (Added 12/30/2020.) U.S. Department of Homeland Security.
This document offers recommendations to owners and operators of cold storage facilities to prepare for cyber threats.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Cybersecurity and Infrastructure Security Agency. (2020). Critical Questions and Considerations for Cold Chain, Storage, and Dry Ice Operations. (Added 12/30/2020.) U.S. Department of Homeland Security.
This list of questions is intended to inform considerations of state, local, territorial, and tribal governments, private sector entities, and cold storage facility owners and operators related to physical security, cyber and infrastructure resiliency, personnel security, and incident response capabilities associated with COVID-19 vaccination logistics.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Cybersecurity and Infrastructure Security Agency. (2020). Physical Security for Cold Storage Locations. (Added 12/30/2020.) U.S. Department of Homeland Security.
This document outlines considerations for the security and integrity of facilities that receive, house, and distribute COVID-19 vaccine.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Cybersecurity and Infrastructure Security Agency. (2020). Primer on Safe and Efficient Handling of Dry Ice. (Added 12/30/2020.) U.S. Department of Homeland Security.
This document provides handling information for owners and operators related to dry ice.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Duke-Margolis Center for Health Policy. (2021). Allocating COVID-19 Vaccines in Initial Phases of Distribution: Federal Recommendations and Considerations for States. (Added 1/11/2021.)
This document reviews federal recommendations and considerations for states in the initial phases of vaccine distribution, reviews the evidence on use for the Pfizer/BioNTech and Moderna vaccines, and compares the two vaccines in a brief table.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Health Resources & Services Administration. (2021). Ensuring Equity in COVID-19 Vaccine Distribution. U.S. Department of Health and Human Services.
This page provides information on administration of COVID-19 vaccines through federally qualified health centers.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
McKesson. (2020). COVID-19 Vaccine Support. (Added 12/30/2020.)
This page describes McKesson’s role in the central distribution of COVID-19 vaccines and ancillary supplies.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* National Governors Association. (2020). Information Systems and Data Flow for COVID-19 Vaccine Distribution and Administration. (Added 12/30/2020.)
This paper discusses the processes and systems involved in the allocation, ordering, distribution, inventory management, tracking, administration, documentation, and reporting involved in the COVID-19 mass vaccination campaign.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Governors Association. (2020). Preparing for the COVID-19 Vaccine and Considerations for Mass Distribution. (Added 12/30/2020.)
This memo offers actions to prepare for the mass distribution of COVID-19 vaccine.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Omnicare. (2020). Vaccine Clinics. (Added 12/30/2020.) CVS Health.
This page shares information on the role of CVS health in the national distribution of COVID-19 vaccine through the Vaccine Clinic Program.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
The Council of State Governments. (2020). State Vaccination Plans. (Added 12/30/2020.)
This page offers clickable maps to access each state’s COVID-19 vaccination plan and additional information from states conducting their own reviews of vaccines prior to distribution.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* U.S. Department of Health and Human Services. (2020). Guidance for PREP Act Coverage for Qualified Pharmacy Technicians and State-Authorized Pharmacy Interns for Childhood Vaccines, COVID-19 Vaccines, and COVID-19 Testing. (Added 12/30/2020.)
This guidance allows state-licensed pharmacists to order and state-licensed pharmacists and registered pharmacy interns to administer COVID-19 vaccines under the Public Readiness and Emergency Preparedness Act when certain requirements are met.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Walgreens. (2020). COVID-19 Vaccine. (Added 12/30/2020.)
This page offers information on the role of Walgreens in the national COVID-19 mass vaccination effort.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Vaccination Logistics – Prioritization

Kates, J., Michaud, J., and Tolbert, J.. (2020). How are States Prioritizing Who Will Get the COVID-19 Vaccine First? (Added 12/30/2020.) Kaiser Family Foundation.
This document analyzes how states prioritized their initial allocations of vaccine to prevent COVID-19, including whether they followed the recommendations of the Advisory Committee on Immunization Practices. Links to each state’s prioritization criteria are included.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Michaud, J. and Kates, J.. (2020). Distributing a COVID-19 Vaccine Across the U.S. – A Look at Key Issues. (Added 12/30/2020.) Kaiser Family Foundation.
This issue brief identifies key issues related to COVID-19 vaccine distribution. Issues discussed include: funding for vaccine distribution; supply, logistics, and monitoring; federal, state, and local authority over vaccine requirements; insurance coverage and out-of-pocket costs; addressing racial and ethnic disparities; and communication and trust.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Michaud, J., Kates, J., Dolan, R., and Tolbert, J.. (2020). States are Getting Ready to Distribute COVID-19 Vaccines. What Do Their Plans Tell Us So Far? (Added 12/30/2020.) Kaiser Family Foundation.
This issue brief describes a review of the 64 state, territorial, and local jurisdictional immunization program COVID-19 vaccine response plans submitted to the Centers for Disease Control and Prevention. The authors summarize how jurisdictions are identifying priority populations for vaccination, identifying a network of providers to administer vaccines, developing data collection and reporting systems to track vaccine distribution, and planning a communication strategy. Also included are links to all publicly available plans.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Academy for State Health Policy. (2020). States Plan for Vaccinating Their Populations Against COVID-19. (Added 12/30/2020.)
This page uses a map and tables to show the populations prioritized in each state by phase of vaccination.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Association of Counties. (2020). Key Considerations for Counties in COVID-19 Vaccine Distribution Plans. (Added 12/30/2020.)
This toolkit provides information to counties to inform planning for equitable local distribution of COVID-19 vaccine.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Governors Association. (2020). Supporting an Equitable Distribution of COVID-19 Vaccines. (Added 12/30/2020.)
This report analyzes the initial drafts of jurisdictional COVID-19 vaccination plans submitted to CDC to identify key issues and promote promising practices.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Health Care for the Homeless Council. (2021). Vaccines for Patients and Staff. (Added 2/4/2021.)
This issue brief assesses how state vaccination plan prioritize people experiencing homelessness and their service providers, factors influencing successful vaccination programs, and action steps for the homeless services community.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
footer

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.